Organisations to explore role of professional bodies in clinical trial transparency

19th September 2013

Two UK based professional bodies are going to explore what the role of professional organizations can support their members in adhering to standards for clinical trial transparency. The British Pharmacological Society (BPS) and the Royal Pharmaceutical Society (RPS) are both signatories to the AllTrials petition. Between them they represent 40,000 members spanning pharmacists, academics, industry, regulatory agencies and health services.

Professor Jayne Lawrence, RPS Chief Scientist and Professor Philip Routledge, BPS President said “We are committed to working productively and proactively with the regulators of research to support their development of standards. We intend to explore with them, and other partners, how professional organizations like BPS and RPS can contribute to achieving transparency in ways that benefit openness in research and patient care.” Read the full statement here.

This is great news from the BPS & RPS in response to the release of our detailed statement. We hope that other bodies worldwide will follow their lead and start discussions on how they can support their members in getting all clinical trials registered and results reported.

If organisations worldwide would be interested to learn more about BPS and RPS plans, please get in touch.